Zeteo Tech, Inc.

Mission & Goals

Zeteo Tech’s revolutionary biological mass spectrometry technology identifies airborne microbes, proteins and lipids, and can be used to screen for infectious disease and other bio-threats. Preliminary measurements demonstrate that we can rapidly and non-invasively screen populations to find individuals likely to have tuberculosis (TB) and other respiratory infections, and at a cost of pennies per person. Because of the high prevalence of TB globally, the emergence of highly drug-resistance strains, and the lack of an effective vaccine, mass patient screening, or “active case finding,” is perhaps the most effective near-term strategy to control the TB epidemic. Zeteo’s innovative and patent-pending time-of-flight mass spec technology dramatically lowers instrument cost and size relative to the MALDI instruments used globally in the clinical diagnostics market today. Our instrument’s high sensitivity enables near real-time screening for disease at the point-of-care, without (...)